European Journal of Medicinal Chemistry p. 770 - 789 (2018)
Update date:2022-08-15
Topics:
Cooper, Anna G.
MacDonald, Christa
Glass, Michelle
Hook, Sarah
Tyndall, Joel D.A.
Vernall, Andrea J.
Cannabinoid type 2 (CB2) receptor continues to emerge as a promising drug target for many diseases and conditions. New tools for studying CB2 receptor are required to further inform how this receptor functions in healthy and diseased states. The alkyl indole scaffold is a well-recognised ligand for cannabinoid receptors, and in this study the indole C5-7 positions were explored for linker and fluorophore attachment. A new high affinity, CB2 receptor selective inverse agonist was identified (16b) along with a general trend of C5-substituted indoles acting as agonists versus C7-substituted indoles acting as inverse agonists. The indole C7 position was found to be the most tolerant to linker extension and resulted in a high affinity inverse agonist with a medium length linker (19). Although a high affinity fluorescent ligand for CB2 receptor was not identified in this study, the indole C7 position shows great promise for fluorophore or probe attachment.
View MoreShanghai ZaiQi Bio-Tech Co., Ltd.,
Contact:+86-21-5482 4098
Address:Bldg. No.7, No.201 MinYi Rd,Songjiang CaoHeJing High-Tech Park Shanghai 201516 P,R,China
Xinji City Taida Sinopec Co., Ltd.
Contact:0086-311-85341278
Address:No.6, Nanhua Road,Xinji City Road,Hebei Province,China
Zhuhai Jiacheng Biological Technology Co., Ltd
Contact:0756-8800233
Address:room 222, Lianhua road , Gongbei ,Zhuhai, Guangdong ,China
Refine Chemicals Science & Technology Technology Developing Co., Ltd.
Contact:+86-22-87899130
Address:No.12,west keyan road,Tianjin City
Contact:+86-574- 87178138; 87297407
Address:No. 809, Liudingxingzuo, cangsong road, Ningbo, China
Doi:10.1039/c1jm12716k
(2011)Doi:10.1021/jm00315a052
(1967)Doi:10.1021/ml200202y
(2011)Doi:10.1055/s-1991-26389
(1991)Doi:10.1021/ja01492a049
(1960)Doi:10.1021/jm200688y
(2011)